chitosan has been researched along with resiquimod in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buffa, V; Doyle-Meyers, L; Fischetti, L; King, DF; Klein, K; Shattock, RJ; Siddiqui, A; Tregoning, JS; Veazey, RS | 1 |
| Abdolalizadeh, J; Amini, Y; Azizian, K; Baradaran, B; Gholizadeh, P; Hasani, A; Hoseinpur, R; Memar, MY; Salehi, R; Samadi Kafil, H | 1 |
2 other study(ies) available for chitosan and resiquimod
| Article | Year |
|---|---|
Evaluation of mucosal adjuvants and immunization routes for the induction of systemic and mucosal humoral immune responses in macaques.
Topics: Adjuvants, Immunologic; Administration, Intranasal; Animals; Antibodies; Antibody Formation; beta-Galactosidase; Chitosan; Cytokines; Female; Hemocyanins; Imidazoles; Immunity, Mucosal; Immunization; Immunoglobulin A; Immunoglobulin G; Inflammation; Injections, Intramuscular; Lipopeptides; Macaca mulatta; Mucous Membrane; Ovalbumin; Poly I-C; Thymic Stromal Lymphopoietin | 2015 |
Chitosan nanoparticles containing fusion protein (Hspx-PPE44-EsxV) and resiquimod adjuvant (HPERC) as a novel booster vaccine for
Topics: Adjuvants, Immunologic; Animals; Antigens, Bacterial; Bacterial Proteins; BCG Vaccine; Chitosan; Escherichia coli; Imidazoles; Immunoglobulin G; Interleukin-17; Interleukin-4; Mice; Mycobacterium tuberculosis; Nanoparticles; Tuberculosis | 2022 |